PLEKHG4 and thyroid gland carcinoma: Yuan et al. investigated the regulatory role of UBE2O in thyroid cancer (TC) progression, and demonstrated that UBE2O modulates the stability of the Pleckstrin homology domain containing family G member 4 (PLEKHG4) to regulate the malignant behavior of thyroid cancer cells [36].